Expert Interview
Gaining insight into the newly approved iLet Bionic Pancreas insulin pump for type 1 diabetes
Ticker(s): BETA BIONICS, TNDM, PODD, ABT, MDTInstitution: Washington University in St. Louis
- Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at WUSTL.
- Former Director of the Clinical Diabetes Center at Washington University School of Medicine and currently manages diabetes patients in the Endocrine Fellows Clinic
- Research interest in diabetes population research, inpatient diabetes management, and post transplant diabetes.
Describe your background and practice setting
Added By: ben_adminHow many patients with type 1 diabetes do you manage?
Added By: ben_adminWhich insulin pumps do your patients currently utilize?
Added By: ben_adminWhat are the most important factors for patients and physicians when considering a new pump?
Added By: ben_adminWhat is your opinion of the newest pump approved from Beta Bionics?
Added By: ben_adminHow many patients do you think you will recommend the iLet Bionic pancreas to in the next 12 months?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
